Ipca Laboratories Ltd.
| BSE: 524494 | Sector: Health care |
| NSE: IPCALAB | ISIN Code: INE571A01038 |
| BSE 00:00 | 03 Feb | 855.50 |
-1.00 (-0.12%) |
OPEN
858.15 |
HIGH
861.75 |
LOW
844.25 |
| NSE 00:00 | 03 Feb | 855.80 |
-1.25 (-0.15%) |
OPEN
855.00 |
HIGH
863.50 |
LOW
843.85 |
| OPEN | 858.15 |
| PREVIOUS CLOSE | 856.50 |
| VOLUME | 2492 |
| 52-Week high | 1089.00 |
| 52-Week low | 830.00 |
| P/E | 33.91 |
| Mkt Cap.(Rs cr) | 21,704 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Ipca Laboratories Ltd. (IPCALAB) - Company Information
Ipca Laboratories Ltd
Ipca Laboratories Limited (IPCA) was incorporated on 19th October 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments. The products of the Company are now sold in over 100 countries across the globe. The Company has 17 ma...> More
| COMPANY INFORMATION | |||||||
| Chairman & MD & CEO : | Premchand Godha | ||||||
| Joint Managing Director & CFO : | A K Jain | ||||||
| Independent Director : | Anand T Kusre | ||||||
| Executive Director : | Pranay Godha | ||||||
| Company Secretary : | Harish P Kamath | ||||||
| Executive Director : | Prashant Godha | ||||||
| Independent Director : | Manisha Premnath | ||||||
| Independent Director : | Kamal Kishore Seth | ||||||
| Additional Director : | Narendra Mairpady | ||||||
| AUDITOR : | G M Kapadia & Co/Natvarlal Vepari & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs & Formln | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 48 Kandivli Industrial Estate, Kandivli (West),Mumbai,Maharashtra-400067 | |||||||
| Ph : 91-22-66474444 | |||||||
| WEBSITE : http://www.ipca.com | |||||||
| E-mail : ipca@ipca.co.in/investors@ipca.com | |||||||
Quick Links for Ipca Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
